<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int J Cardiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Int. J. Cardiol</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Cardiology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0167-5273</issn>
      <issn pub-type="epub">1874-1754</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24456888</article-id>
      <article-id pub-id-type="pmc">3991337</article-id>
      <article-id pub-id-type="publisher-id">S0167-5273(13)02329-2</article-id>
      <article-id pub-id-type="doi">10.1016/j.ijcard.2013.12.117</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Secondary amyloidosis in an alkaptonuric aortic valve<sup><xref ref-type="fn" rid="d32e234">&#x2606;</xref></sup></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Millucci</surname>
            <given-names>Lia</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="fn0005" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ghezzi</surname>
            <given-names>Lorenzo</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Braconi</surname>
            <given-names>Daniela</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Laschi</surname>
            <given-names>Marcella</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Geminiani</surname>
            <given-names>Michela</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Amato</surname>
            <given-names>Loredana</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Orlandini</surname>
            <given-names>Maurizio</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Benvenuti</surname>
            <given-names>Chiara</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bernardini</surname>
            <given-names>Giulia</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="fn0005" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santucci</surname>
            <given-names>Annalisa</given-names>
          </name>
          <email>annalisa.santucci@unisi.it</email>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="cr0005" ref-type="corresp">&#x204E;</xref>
        </contrib>
      </contrib-group>
      <aff id="af0005"><label>a</label>Dipartimento di Biotecnologie, Chimica e Farmacia, via Fiorentina 1, Universit&#xE0; degli Studi di Siena, Siena, Italy</aff>
      <aff id="af0010"><label>b</label>Medicina e Riattivazione Cardiologica DAI Cuore e Vasi, AOUS Careggi, Firenze, Italy</aff>
      <author-notes>
        <corresp id="cr0005"><label>&#x204E;</label>Corresponding author at: Dipartimento di Biotecnologie, Chimica e Farmacia, via Fiorentina 1, 53100 Siena, Italy. Tel.: +&#xA0;39 0577234958; fax: +&#xA0;39 0577234903. <email>annalisa.santucci@unisi.it</email></corresp>
        <fn id="fn0005">
          <label>1</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>3</month>
        <year>2014</year>
      </pub-date>
      <volume>172</volume>
      <issue>1</issue>
      <fpage>e121</fpage>
      <lpage>e123</lpage>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>10</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2013 The Authors</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).</license-p>
        </license>
      </permissions>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Ochronosis</kwd>
        <kwd>Amyloidosis</kwd>
        <kwd>Aortic valve</kwd>
        <kwd>Stenosis</kwd>
        <kwd>Calcification</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Alkaptonuria (AKU) is an ultra-rare disease developed from the lack of homogentisate 1,2-dioxygenase activity, causing an accumulation of homogentisic acid (HGA) in pigmented deposits (ochronosis) in connective tissues, especially in the joints and heart. AKU is mostly asymptomatic in early life, with arthropathy and cardiovascular symptoms appearing in later decades of life. Cardiovascular involvement has been described in as many as 40% of AKU patients (mean and median age of detection being 54 and 52&#xA0;years, respectively) <xref rid="bb0005" ref-type="bibr">[1]</xref>. Alkaptonuric ochronosis can be treated symptomatically during the early stages, whereas for end stages total joint and heart valve replacements may be required <xref rid="bb0005 bb0010 bb0015" ref-type="bibr">[1&#x2013;3]</xref>, but no specific cure exists at the moment, although a phase II clinical trial with nitisinone is in progress.</p>
    <p>Thanks to the use of our in vitro, cell and tissue AKU models <xref rid="bb0020 bb0025 bb0030 bb0035 bb0040 bb0045 bb0050" ref-type="bibr">[4&#x2013;10]</xref>, we recently provided experimental evidence that AKU is a secondary serum amyloid A (SAA)-based amyloidosis <xref rid="bb0040" ref-type="bibr">[8]</xref>. A co-localization of ochronotic pigment and SAA-amyloid was also reported <xref rid="bb0040" ref-type="bibr">[8]</xref>.</p>
    <p>In the present work, using Congo Red (CR) birefringence and immunofluorescence, we report for the first time the presence of SAA-amyloidosis in the stenotic aortic valve of an AKU patient. Light microscopy revealed a co-localization of ochronotic pigment and SAA-amyloid, tissue calcification, lipid oxidation, inflammation, and tissue degeneration.</p>
    <p>Alkaptonuric specimen was obtained from a patient (<xref rid="t0005" ref-type="table">Table&#xA0;1</xref>) who underwent biologic aortic valve replacement. AKU patient had been previously diagnosed for secondary amyloidosis as SAA-amyloid had been detected in her cartilage and synovia <xref rid="bb0040" ref-type="bibr">[8]</xref>. Echocardiogram revealed severe aortic stenosis with an aortic transvalvular mean gradient of 53&#xA0;mm&#xA0;Hg, a peak transvalvular gradient of 89, a peak of systolic velocity (m/s) of 4.7 and valve area of 0.82&#xA0;cm<sup>2</sup> and an AVA indexed for body weight of 0.52&#xA0;cm<sup>2</sup>. Inter-ventricular septal thickness was 12&#xA0;mm. Left ventricular systolic function was preserved. In view of the severe aortic stenosis the patient underwent elective aortic valve replacement. The postoperative course was uneventful and the patient recovered well from surgery at one-year follow-up.</p>
    <p>After surgery AKU aortic valve sections were stained with eosin/hematoxylin, CR stained for amyloid detection or used for immunofluorescence staining with anti-SAA and anti-4-hydroxy-2-nonenal (4-HNE) antibodies.</p>
    <p>At a glance, the aortic valve revealed massive deposits of ochronotic pigment with calcification in the cusps (<xref rid="f0005" ref-type="fig">Fig.&#xA0;1</xref>A). Sclerotic change in the cusps, and shrinkage of the non-coronary cusp, impeding normal coaptation of the aortic valve, associated with diffuse ochronotic deposition, appeared to be the causative lesions of the need for aortic valve replacement. Ochronosis was associated with areas of valvular calcification. Light microscopy examinations consistently showed severe calcification involving surface endothelium (<xref rid="f0005" ref-type="fig">Fig.&#xA0;1</xref>B). CR staining detected the presence of diffuse amyloid, mainly located in densely sclerotic and poorly vascularised scar tissue and co-localization of amyloid and ochronotic pigment was visible in close proximity to calcific deposits (<xref rid="f0005" ref-type="fig">Fig.&#xA0;1</xref>C). Co-localization of SAA deposition with ochronotic pigmentation was detected (<xref rid="f0005" ref-type="fig">Fig.&#xA0;1</xref>D). Major products of lipid peroxidation (LPO) were detected in AKU valve sections incubated with anti-4-HNE antibody (<xref rid="f0005" ref-type="fig">Fig.&#xA0;1</xref>E). LPO were perfectly superimposing to pigmented areas, suggesting the association of intraleaflet ochronosis and oxidative stress (<xref rid="f0005" ref-type="fig">Fig.&#xA0;1</xref>E). AKU valve also contained macrophages in the subendothelial layer of the fibrosa, in the vicinity of ochronotic deposits, and along the lamina elastic (<xref rid="f0005" ref-type="fig">Fig.&#xA0;1</xref>B). An evident co-localization between oxidized lipids, inflammation and ochronosis suggested that LPO might play a role in the disease process.</p>
    <p>Our present investigation confirmed the hitherto unsuspected existence of AKU-linked secondary amyloidosis, involving also the cardiac district. The present case report is therefore a new rare case of SAA amyloidosis in the heart.</p>
    <p>The striking co-localization of pigment and amyloid suggested that HGA might be involved in amyloid deposition in the heart.</p>
    <p>In conclusion, the emerging view in this AKU case is that valve calcification represents a meeting of lipid oxidation with chronic inflammation and amyloid deposition. In AKU cases, surgical replacement of aortic valves results in significant improvement. Physicians and surgeons should be aware of multiple system involvement in this disorder, as early recognition and appropriate treatment may significantly improve the quality of life in AKU patients.</p>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bb0005">
        <label>1</label>
        <element-citation publication-type="journal" id="rf0050">
          <person-group person-group-type="author">
            <name>
              <surname>Thakur</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Markman</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Cullen</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Choice of valve prosthesis in a rare clinical condition: aortic stenosis due to alkaptonuria</article-title>
          <source>Heart Lung Circ</source>
          <volume>22</volume>
          <issue>10</issue>
          <year>2013</year>
          <fpage>870</fpage>
          <lpage>872</lpage>
          <pub-id pub-id-type="pmid">23357094</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0010">
        <label>2</label>
        <element-citation publication-type="journal" id="rf0005">
          <person-group person-group-type="author">
            <name>
              <surname>Hiroyoshi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Panthee</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Aortic valve replacement for aortic stenosis caused by alkaptonuria</article-title>
          <source>Ann Thorac Surg</source>
          <volume>95</volume>
          <year>2013</year>
          <fpage>1076</fpage>
          <lpage>1079</lpage>
          <pub-id pub-id-type="pmid">23438536</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0015">
        <label>3</label>
        <element-citation publication-type="journal" id="rf0010">
          <person-group person-group-type="author">
            <name>
              <surname>Lok</surname>
              <given-names>Z.S.</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Alkaptonuria-associated aortic stenosis</article-title>
          <source>J Card Surg</source>
          <volume>28</volume>
          <year>2013</year>
          <fpage>417</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="pmid">23879342</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0020">
        <label>4</label>
        <element-citation publication-type="journal" id="rf0015">
          <person-group person-group-type="author">
            <name>
              <surname>Braconi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bernardini</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bianchini</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>A biochemical and proteomic characterization of alkaptonuric chondrocytes</article-title>
          <source>J Cell Physiol</source>
          <volume>227</volume>
          <year>2012</year>
          <fpage>3333</fpage>
          <lpage>3343</lpage>
          <pub-id pub-id-type="pmid">22213341</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0025">
        <label>5</label>
        <element-citation publication-type="journal" id="rf0020">
          <person-group person-group-type="author">
            <name>
              <surname>Braconi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Bianchini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bernardini</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis</article-title>
          <source>J Inherit Metab Dis</source>
          <volume>34</volume>
          <year>2011</year>
          <fpage>1163</fpage>
          <lpage>1176</lpage>
          <pub-id pub-id-type="pmid">21874298</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0030">
        <label>6</label>
        <element-citation publication-type="journal" id="rf0025">
          <person-group person-group-type="author">
            <name>
              <surname>Braconi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Laschi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Amato</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis</article-title>
          <source>Rheumatology (Oxford)</source>
          <volume>49</volume>
          <year>2010</year>
          <fpage>1975</fpage>
          <lpage>1983</lpage>
          <pub-id pub-id-type="pmid">20601653</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0035">
        <label>7</label>
        <element-citation publication-type="journal" id="rf0055">
          <person-group person-group-type="author">
            <name>
              <surname>Braconi</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Laschi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>A.M.</given-names>
            </name>
          </person-group>
          <article-title>Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes</article-title>
          <source>J Cell Biochem</source>
          <volume>111</volume>
          <year>2010</year>
          <fpage>922</fpage>
          <lpage>932</lpage>
          <pub-id pub-id-type="pmid">20665660</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0040">
        <label>8</label>
        <element-citation publication-type="journal" id="rf0035">
          <person-group person-group-type="author">
            <name>
              <surname>Millucci</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Spreafico</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Tinti</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Alkaptonuria is a novel human secondary amyloidogenic disease</article-title>
          <source>Biochim Biophys Acta</source>
          <volume>2012</volume>
          <year>1822</year>
          <fpage>1682</fpage>
          <lpage>1689</lpage>
        </element-citation>
      </ref>
      <ref id="bb0045">
        <label>9</label>
        <element-citation publication-type="journal" id="rf0040">
          <person-group person-group-type="author">
            <name>
              <surname>Tinti</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Spreafico</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Braconi</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model</article-title>
          <source>J Cell Physiol</source>
          <volume>225</volume>
          <year>2010</year>
          <fpage>84</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">20648626</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0050">
        <label>10</label>
        <element-citation publication-type="journal" id="rf0045">
          <person-group person-group-type="author">
            <name>
              <surname>Tinti</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Santucci</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Development of an in vitro model to investigate joint ochronosis in alkaptonuria</article-title>
          <source>Rheumatology (Oxford)</source>
          <volume>50</volume>
          <year>2011</year>
          <fpage>271</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="pmid">20952450</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack id="ac0005">
      <title>Acknowledgments</title>
      <p>This work has been supported by <funding-source id="gts0005">TELETHON ITALY</funding-source> grant GGP10058.</p>
      <p>The authors thank the alkaptonuric patient who generously donated her aortic valve for the present study, <funding-source id="gts0010">AimAKU (Associazione Italiana Malati di Alcaptonuria</funding-source>, ORPHA263402), Toscana Life Sciences Orphan_1 project and Fondazione Monte dei Paschi di Siena 2008&#x2013;2010.</p>
    </ack>
    <fn-group>
      <fn id="d32e234">
        <label>&#x2606;</label>
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig.&#xA0;1</label>
      <caption>
        <p>A) Macroscopic aspect of AKU aortic valve showing a rough surface of the leaflets and ochronotic pigmentation on the surface. A thickening of the central areas of the cusps with nodule-like structures is visible (arrow). B) Light microscopy (hematoxylin and eosin staining) examinations of AKU aortic valve with intense inflammatory cell infiltrate that includes large cells macroscopically corresponding to macrophages (arrows). Magnification 20&#xA0;&#xD7;. C) Congo Red staining of AKU aortic valve amyloid deposits. Left: unpolarized light. Valve tissue was ever stained red (&#x201C;congophilic&#x201D;); Right: polarized light. The pigmented areas (arrows) were also birefringent, indicating overlapping of ochronosis and amyloid. Magnification 40&#xA0;&#xD7;. D) SAA was present in AKU aortic valve amyloid deposits. Positive staining for SAA-amyloid was particularly intense in correspondence of ochronotic pigmentation. Magnification 20&#xA0;&#xD7;. E) Immunoreactivity for 4-HNE in AKU aortic valve leaflet. The presence of 4-HNE in the AKU valve was uniformly diffused and the distribution of 4-HNE-positive area was perfectly superimposing to ochronotic pigmented areas. The presence of lipid peroxidation and ochronotic pigment was found to be strictly related to areas of lymphocytes accumulation. Magnification 20&#xA0;&#xD7;.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <table-wrap id="t0005" position="float">
      <label>Table&#xA0;1</label>
      <caption>
        <p>Clinical history of the patient.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Sex year of birth</th>
            <th align="left">Female 1948</th>
            <th align="left"/>
            <th align="left"/>
            <th align="left"/>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">1985</td>
            <td align="left">Meniscus break (L)</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">1986</td>
            <td align="left">3 lumbosciatica attacks</td>
            <td align="left">Reduction in spinal discs</td>
            <td align="left">Spondylolisthesis</td>
            <td align="left">AKU diagnosis</td>
          </tr>
          <tr>
            <td align="left">1987</td>
            <td align="left">Low proteins diet: no results</td>
            <td align="left">Tiroxina with C protein</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">1989</td>
            <td align="left">Meniscus break (R)</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">1994</td>
            <td align="left">Achilles' tendon thickening (L)</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">1997</td>
            <td align="left">Drooling</td>
            <td align="left">Hiatus hernia</td>
            <td align="left">Esophagitis (II degree)</td>
            <td/>
          </tr>
          <tr>
            <td align="left">1998</td>
            <td align="left">Ulna and radial head capitellum break (R)</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">2001</td>
            <td align="left">Knee rotuleus tendon break (L)</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">2003</td>
            <td align="left">Macroglossia</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">2005</td>
            <td align="left">Thyroid removal</td>
            <td align="left">Hip prosthesis (R) with bone replacement</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">2006</td>
            <td align="left">Hip prosthesis (L)</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">2008</td>
            <td align="left">Tachycardia</td>
            <td align="left">Aortic valve stenosis</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">2010</td>
            <td align="left">2 ribs break</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">2011</td>
            <td align="left">Aortic valve replacement</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">AKU features</td>
            <td align="left">Elbows and heels bursitis</td>
            <td align="left">Shoulder pain</td>
            <td align="left">15&#xA0;cm decline of height</td>
            <td align="left">Amyloid deposits in cartilage, synovia and aortic valve</td>
          </tr>
          <tr>
            <td align="left">SAA plasma level</td>
            <td align="left">110&#xA0;mg/L</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">SAP plasma level</td>
            <td align="left">50&#xA0;&#x3BC;g/L</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">HGA plasma level</td>
            <td align="left">11&#xA0;&#x3BC;g/mL</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">HGA urine excretion</td>
            <td align="left">8.6&#xA0;g/day</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">HGD Mutation</td>
            <td align="left">G270R</td>
            <td/>
            <td/>
            <td/>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
